Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylaxis Against Surgical Site Infections Using Local and Systemic Antibiotics
NCT07478874Completed
- Sponsor
- Lahore General Hospital
- Start
- Jul 2025
- Primary completion
- Dec 2025
- Modality
- Nanoparticles, Implantable Devices, Transdermal Patches
- Countries
- 1
01
Overview
Randomised trial of gentamicin in surgical site infection (SSI) (2 arms), sponsored by Lahore General Hospital. Primary endpoint: Frequency of Surgical Site Infection at 30 days. Started Jul 2025; status: completed.
02
Drugs
gentamicin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT07478874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07478874.